Ionising radiation

Malignant neoplasm of the bile duct - Ionising radiation Factor

Last reviewed for CCPS 18 July 2007.

Investigative Documents

Claimant Report - Exposure to Ionising Radiation from Alpha Particles [CR9264]

Preliminary questions [27903]

36217

there is some evidence that ionising radiation may be a factor in the development of the condition under consideration.

36218 the veteran has received ionising radiation from internal deposition of a substance which emits alpha particles at some time.

37918

the veteran has received ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles at some time.

37920 — the veteran has established the causal connection between ionising radiation and VEA service for the clinical onset of malignant neoplasm of the bile duct.

37921 — the veteran has established the causal connection between ionising radiation and operational service for the clinical onset of malignant neoplasm of the bile duct.

or

37922 — the veteran has established the causal connection between ionising radiation and eligible service for the clinical onset of malignant neoplasm of the bile duct.

Clinical onset and operational service [37921]

37923

on operational service, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles.

37925

on operational service, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration.

37935

the veteran receiving a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration, on operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

37928

the veteran received ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles due to an illness or injury which is identifiable.

37929 as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles.

37931

as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles at least two years before the clinical onset of the condition under consideration.

37933 — the identified illness or injury, as a consequence of which the veteran received a cumulative equivalent dose of at least 0.05 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles, is causally related to operational service.

Clinical onset and eligible service [37922]

37924

on eligible service, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles.

37926

as a causal result of eligible service, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles.

37927

as a causal result of eligible service, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles at least five years before the clinical onset of the condition under consideration.

37936

the veteran receiving a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles at least five years before the clinical onset of the condition under consideration, on eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.

or

37928

the veteran received ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles due to an illness or injury which is identifiable.

37930 as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles.

37932

as a consequence of the identified illness or injury, the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles at least five years before the clinical onset of the condition under consideration.

37934 — the identified illness or injury, as a consequence of which the veteran received a cumulative equivalent dose of at least 0.5 Sievert of ionising radiation to the site affected by malignant neoplasm of the bile duct from internal deposition of a substance which emits alpha particles, is causally related to eligible service.